0001127602-22-005752.txt : 20220218
0001127602-22-005752.hdr.sgml : 20220218
20220218161309
ACCESSION NUMBER: 0001127602-22-005752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220216
FILED AS OF DATE: 20220218
DATE AS OF CHANGE: 20220218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loose Christopher R.
CENTRAL INDEX KEY: 0001785299
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 22652863
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-16
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785299
Loose Christopher R.
C/O FREQUENCY THERAPEUTICS, INC.
75 HAYDEN AVE, SUITE 300
LEXINGTON
MA
02421
1
Chief Scientific Officer
Common Stock
2022-02-16
4
S
0
851
4.429
D
37770
D
Common Stock
2022-02-17
4
S
0
900
4.193
D
36870
D
Restricted Stock Unit
2022-02-17
4
A
0
150000
0
A
Common Stock
150000
150000
D
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.29 to $4.54. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.00 to $4.48. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The restricted stock units will fully vest on July 4, 2023.
/s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose
2022-02-18